 |
Homology Medicines
Last updated: January 20, 2024
Arthur Tzianabos, CEO & President
Country: USA | Funding: $187M (+)
Website: https://www.homologymedicines.com/
Homology Medicines is a genetic medicines company translating proprietary, cutting-edge gene editing and gene therapy technology into cures for patients with rare diseases. It is taking a slightly different tack from other players in the gene-editing domain with its adeno-associated virus (AAV) technology AMEnDR. It’s a different approach to other techniques such as CRISPR/cas9 or zinc finger nucleases
Website: https://www.homologymedicines.com/
Homology Medicines is a genetic medicines company translating proprietary, cutting-edge gene editing and gene therapy technology into cures for patients with rare diseases. It is taking a slightly different tack from other players in the gene-editing domain with its adeno-associated virus (AAV) technology AMEnDR. It’s a different approach to other techniques such as CRISPR/cas9 or zinc finger nucleases
